MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease

Nature Communications

Volumn 6, Issue , 2015, Pages

  Millar, Neal L ^a   Gilchrist, Derek S ^a   Akbar, Moeed ^a   Reilly, James H ^a   Kerr, Shauna C ^a   Campbell, Abigail L ^a   Murrell, George A C ^b   Liew, Foo Y ^a,c   Kurowska Stolarska, Mariola ^a   McInnes, Iain B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERLEUKIN 33; MICRORNA 29A; PROTEIN ST2; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN 1BETA; LUCIFERASE; MICRORNA; MIRN29 MICRORNA, HUMAN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

DAMAGE; DISEASE INCIDENCE; GENE EXPRESSION; INJURY; MOLECULAR ANALYSIS; PATHOLOGY; PHYSIOLOGY; RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; INFLAMMATION; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; TENDINITIS; TENDON DISEASE; TENDON INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; REPORTER GENE; SIGNAL TRANSDUCTION; TENDON;

ANIMALS; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-33; LUCIFERASES; MICE; MICRORNAS; PRIMARY CELL CULTURE; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TENDINOPATHY; TENDONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927145585     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7774     Document Type: Article

References (54)

1. Eming, S. A., Krieg, T. & Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514-525 (2007).
2. McCormick, A., Charlton, J. & Fleming, D. Assessing health needs in primary care. Morbidity study from general practice provides another source of information. BMJ 310, 1534 (1995).
3. Khan, K. M., Cook, J. L., Bomar, F., Harcourt, P. & Astrom, M. Histopathology of common tendinopathies. Update and clinical management Sports Med 27, 393-408 (1999).
4. Sharma, P. & Maffulli, N. Tendon injury and tendinopathy: healing and repair. J. Bone Joint Surg. Am. 87, 187-202 (2005).
5. Millar, N. L., Wei, A. Q., Molloy, T. J., Bonar, F. & Murrell, G. A. Cytokines and apoptosis in supraspinatus tendinopathy. J. Bone Joint Surg. Br. 91, 417-424 (2009).
6. Pufe, T., Petersen, W., Tillmann, B. & Mentlein, R. The angiogenic peptide vascular endothelial growth factor is expressed in foetal and ruptured tendons. Virchows Arch. 439, 579-585 (2001).
7. Tsuzaki, M. et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J. Orthop. Res. 21, 256-264 (2003).
8. Tohyama, H., Yasuda, K., Uchida, H. & Nishihira, J. The responses of extrinsic fibroblasts infiltrating the devitalised patellar tendon to IL-1beta are different from those of normal tendon fibroblasts. J. Bone Joint Surg. Br. 89, 1261-1267 (2007).
9. John, T. et al. Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. J. Orthop. Res. 28, 1071-1077 (2010).
10. Lin, T. W., Cardenas, L., Glaser, D. L. & Soslowsky, L. J. Tendon healing in interleukin-4 and interleukin-6 knockout mice. J. Biomech. 39, 61-69 (2006).
11. Gulotta, L. V., Kovacevic, D., Cordasco, F. & Rodeo, S. A. Evaluation of tumor necrosis factor alpha blockade on early tendon-to-bone healing in a rat rotator cuff repair model. Arthroscopy 27, 1351-1357 (2011).
12. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
13. Lefrancais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl Acad. Sci. USA 109, 1673-1678 (2012).
14. Kakkar, R., Hei, H., Dobner, S. & Lee, R. T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 287, 6941-6948 (2012).
15. Lamkanfi, M. & Dixit, V. M. IL-33 raises alarm. Immunity 31, 5-7 (2009).
16. Liew, F. Y., Pitman, N. I. & McInnes, I. B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110 (2010).
17. Asirvatham, A. J., Magner, W. J. & Tomasi, T. B. miRNA regulation of cytokine genes. Cytokine 45, 58-69 (2009).
18. Pritchard, C. C., Cheng, H. H. & Tewari, M. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 13, 358-369 (2012).
19. Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl Acad. Sci. USA 105, 10913-10918 (2008).
20. Zaiss, M. M. et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J. Immunol. 186, 6097-6105 (2011).
21. Rankin, A. L. et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J. Immunol. 184, 1526-1535 (2010).
22. Matthews, T. J., Hand, G. C., Rees, J. L., Athanasou, N. A. & Carr, A. J. Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases. J. Bone Joint Surg. Br. 88, 489-495 (2006).
23. Millar, N. L. et al. Inflammation is present in early human tendinopathy. Am. J. Sports Med. 38, 2085-2091 (2010).
24. Ogawa, T. et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 391, 316-321 (2010).
25. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
26. Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat. Immunol. 12, 861-869 (2011).
27. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (2007).
28. Maurer, B. et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 62, 1733-1743 (2010).
29. Di Giammartino, D. C., Nishida, K. & Manley, J. L. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43, 853-866 (2011).
30. Basu, S., Binder, R. J., Suto, R., Anderson, K. M. & Srivastava, P. K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546 (2000).
31. Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195 (2002).
32. Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521 (2003).
33. Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851-856 (2007).
34. Eigenbrod, T., Park, J. H., Harder, J., Iwakura, Y. & Nunez, G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J. Immunol. 181, 8194-8198 (2008).
35. Moussion, C., Ortega, N. & Girard, J. P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 3, e3331 (2008).
36. Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl Acad. Sci. USA 106, 9021-9026 (2009).
37. James, R., Kesturu, G., Balian, G. & Chhabra, A. B. Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options. J. Hand Surg. Am. 33, 102-112 (2008).
38. Brown, B. D. & Naldini, L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10, 578-585 (2009).
39. Abonnenc, M. et al. Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ. Res. 113, 1138-1147 (2013).
40. Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218 (2011).
41. Sengupta, S. et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl Acad. Sci. USA 105, 5874-5878 (2008).
42. Abrahams, Y., Laguette, M. J., Prince, S. & Collins, M. Polymorphisms within the COL5A1 3'-UTR that alters mRNA structure and the MIR608 gene are associated with Achilles tendinopathy. Ann. Hum. Genet. 77, 204-214 (2013).
43. Mendias, C. L., Gumucio, J. P. & Lynch, E. B. Mechanical loading and TGF-beta change the expression of multiple miRNAs in tendon fibroblasts. J. Appl. Physiol. (1985) 113, 56-62 (2012).
44. Cushing, L. et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 45, 287-294 (2011).
45. Wei, W. et al. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis. 4, e668 (2013).
46. Millar, N. L. et al. Hypoxia: a critical regulator of early human tendinopathy. Ann. Rheum. Dis. 71, 302-310 (2012).
47. Millar, N. L., Wei, A. Q., Molloy, T. J., Bonar, F. & Murrell, G. A. Heat shock protein and apoptosis in supraspinatus tendinopathy. Clin. Orthop. Relat. Res. 466, 1569-1576 (2008).
48. Millar, N. L., Wu, X., Tantau, R., Silverstone, E. & Murrell, G. A. Open versus two forms of arthroscopic rotator cuff repair. Clin. Orthop. Relat. Res. 467, 966-978 (2009).
49. McInnes, I. B. et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184, 1519-1524 (1996).
50. Dirks, R. C. & Warden, S. J. Models for the study of tendinopathy. J. Musculoskelet. Neuronal. Interact. 11, 141-149 (2011).
51. Khan, K. M., Cook, J. L., Bonar, F., Harcourt, P. & Astrom, M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med. 27, 393-408 (1999).
52. Kurowska-Stolarska, M. et al. IL-33 induces antigen-specific IL-5 + T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181, 4780-4790 (2008).
53. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
54. Hedrick, M. N. et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119, 2317-2329 (2009).